Journey of Resilience
Living with ALK+ Lung Cancer: A 4-Year Journey of Strength
How Targeted Therapies, Creativity, and a Supportive Network Empower a Life Beyond Diagnosis
Eva, a resident of North Rhine-Westphalia (NRW), has been living with ALK-positive non-small cell lung cancer (NSCLC) for four years. This diagnosis appeared unexpectedly in 2019, when she was adjusting to a new home, settling into a new job as a preschool teacher, and dealing with what initially seemed like a stubborn cold.
Concerned by persistent coughing and traces of blood, she insisted on a referral to a pulmonologist. An x-ray revealed a suspicious area on the lung, initially thought to be an atypical pneumonia. Further investigation, including bronchoscopy and tissue testing, confirmed a non-small cell lung cancer. Genetic analysis then revealed the ALK mutation, opening the door to targeted treatments.
Living with advanced lung cancer has reshaped many aspects of Eva’s life, but she continues to find joy and meaning. Together with her husband, younger daughter, and two dogs, she maintains an active lifestyle that includes learning to sail—a passion she shares with her husband—while also nurturing her creative side through painting. Equally important to her well-being is an active engagement in the lung cancer community. Eva has helped organize gatherings for people living with ALK+ NSCLC, offering a space where mutual support and understanding can flourish.
These community connections not only bring comfort, but also equip individuals with insights into the latest research and treatments. Sharing stories and coping strategies makes the path less isolating, affirming that challenges can be met with both resilience and hope. Through this collective support, Eva finds a sense of control and optimism about her future.
Today, Eva’s outlook remains positive thanks to targeted therapies designed for the ALK mutation, regular medical follow-ups, and a supportive network of family, friends, and fellow patients. By blending professional care, creative pursuits, and meaningful connections, she demonstrates that living with lung cancer does not preclude a fulfilling and joyful life.
Diagnosis
Non-small cell lung cancer (NSCLC) diagnosed in 2019
Biomarker profile: ALK-positive
Treatment
Targeted therapy and supportive care, including regular monitoring
Outcome
Four years of resilience, an active lifestyle, and dedicated community advocacy
Source: Das K Wort (Published in November 2023)